These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 377648)

  • 1. Diagnosis and treatment of acute cardiac allograft rejection.
    Oyer PE; Stinson EB; Bieber CP; Reitz BA; Raney AA; Baumgartner WA; Shumway NE
    Transplant Proc; 1979 Mar; 11(1):296-303. PubMed ID: 377648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current expectations in cardiac transplantation.
    Baumgartner WA; Reitz BA; Bieber CP; Oyer PE; Shumway NE; Stinson EB
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):525-30. PubMed ID: 347177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac transplantation--1980: The Medical College of Virginia program.
    Hastillo A; Hess ML; Richardson DW; Lower RR
    South Med J; 1980 Jul; 73(7):909-11. PubMed ID: 6992284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
    Foerster A; Simonsen S; Frøysaker T
    APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of changed histopathologic appearance of acute rejection in cardiac allografts after prophylactic application of OKT3.
    Kemnitz J; Cremer J; Schaefers HJ; Restrepo-Specht I; Haverich A; Uysal A; Heublein B; Wirth S
    J Heart Lung Transplant; 1991; 10(3):366-72. PubMed ID: 1906746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac transplantation at Stanford.
    Copeland JG; Stinson EB; Griepp RB; Shumway NE
    Acta Chir Belg; 1977; 76(3):387-92. PubMed ID: 331818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplantation--a two-year experience.
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Borst HG
    Z Kardiol; 1985; 74 Suppl 6():51-8. PubMed ID: 3913180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
    Wei J; Chang CY; Lee FY; Song YB; Jiau SF
    Transplant Proc; 1992 Aug; 24(4):1493-7. PubMed ID: 1496632
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of T-cell phenotype characterization in endomyocardial biopsy fragments from human cardiac allografts.
    Higuchi ML; de Assis RV; Sambiase NV; Reis MM; Kalil J; Bocchi E; Fiorelli A; Stolf N; Bellotti G; Pileggi F
    J Heart Lung Transplant; 1991; 10(2):235-42. PubMed ID: 1674430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies of immunosuppression in cardiac transplantation.
    Renlund DG; O'Connell JB; Bristow MR
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive implications of bioptic diagnosis in cardiac allografts.
    Kemnitz J; Choritz H; Cohnert TR; Haverich A; Borst HG; Georgii A
    J Heart Transplant; 1989; 8(4):315-29. PubMed ID: 2671317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 19. The postsurgical heart. The pathology of cardiac transplantation.
    Billingham ME
    Am J Cardiovasc Pathol; 1988; 1(3):319-34. PubMed ID: 3061403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac transplantation for endstage heart disease.
    Argenziano M; Michler RE; Rose EA
    Heart Vessels; 1997; Suppl 12():23-7. PubMed ID: 9476536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.